NEW YORK (GenomeWeb News) – The Eurofins Group, an international bioanalytical testing provider, said this week that it has formed a genomics business unit called Eurofins Genomics that will consolidate the operations of Operon Biotechnologies, which it recently acquired, and two existing Eurofins subsidiaries.
 
As a result, Eurofins Genomics is planning to close two European facilities and one US site, GenomeWeb Daily News has learned.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.